Key Metrics
Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
- PublisherBENTHAM SCIENCE PUBL LTD
- LanguageEnglish
- FrequencyBi-monthly
- LanguageEnglish
- FrequencyBi-monthly
- Publication Start Year2001
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Endocrine, Metabolic and Immune Disorders - Drug Targets been publishing? 
The Endocrine, Metabolic and Immune Disorders - Drug Targets has been publishing since 2001 till date.
How frequently is the Endocrine, Metabolic and Immune Disorders - Drug Targets published? 
Endocrine, Metabolic and Immune Disorders - Drug Targets is published Bi-monthly.
Who is the publisher of Endocrine, Metabolic and Immune Disorders - Drug Targets? 
The publisher of Endocrine, Metabolic and Immune Disorders - Drug Targets is BENTHAM SCIENCE PUBL LTD.
How can I view the journal metrics of Endocrine, Metabolic and Immune Disorders - Drug Targets on editage? 
For the Endocrine, Metabolic and Immune Disorders - Drug Targets metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Endocrine, Metabolic and Immune Disorders - Drug Targets? 
The eISSN number is 2212-3873 and pISSN number is 1871-5303 for Endocrine, Metabolic and Immune Disorders - Drug Targets.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.